Fmoc-alpha-allyl-DL-Gly-OH is an Fmoc-protected glycine derivative bearing an allyl substituent at the alpha position, placing it in the class of protected, structurally modified amino acids used as peptide-building blocks. The molecule contains a carboxyl group and an amino functionality masked by the Fmoc carbamate, while the allyl side substituent provides a carbon-carbon double bond for chemical functionalization; the "DL" designation indicates a racemic mixture at the alpha stereocenter. In peptide chemistry, this protected analogue is employed in stepwise peptide synthesis workflows where the Fmoc group controls chemoselectivity during coupling, and the allyl handle can be carried through synthesis for subsequent derivatization or conjugation strategies.
CAT No: CP26818
CAS No:221884-63-5
Synonyms/Alias:Fmoc-alpha-allyl-DL-glycine;221884-63-5;FMOC-DL-allylglycine;SS-3924;FMOCDLallylglycine;AC1N2Q97;SCHEMBL15585491;CTK8B2931;2-(9H-fluoren-9-ylmethoxycarbonylamino)pent-4-enoicAcid;MolPort-009-196-571;ANW-41375;D-2-Allylglycine,N-FMOCprotected;L-2-Allylglycine,N-FMOCprotected;AKOS005073844;RP16741;RTR-010452;VZ36572;VZ36581;TR-010452;FT-0681831;N-FLUORENEMETHOXYCARBONYL-D-ALLYLGLYCINE;N-FLUORENEMETHOXYCARBONYL-L-ALLYLGLYCINE;Fmoc-2-amino-4-pentenoicacid,Fmoc-allylglycine;2-(9H-Fluorene-9-ylmethoxycarbonylamino)-4-pentenoicacid;2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}pent-4-enoicacid
Fmoc-alpha-allyl-DL-Gly-OH is an Fmoc-protected glycine derivative bearing an allyl substituent at the alpha position, presented as a DL (racemic) mixture that contains both stereochemical configurations at the chiral center. The molecule combines a fluorenylmethoxycarbonyl (Fmoc) group on the amino function with a free carboxylic acid, enabling controlled N-protection and subsequent peptide-coupling chemistry under standard solid-phase or solution-phase conditions. The allyl-bearing side functionality introduces an alkene handle that can undergo radical, oxidative, or metathesis-based transformations after incorporation into peptides or after orthogonal functional-group manipulation. The presence of both protected amine and unprotected acid, together with the reactive allyl group, makes the compound a practical chiral amino acid intermediate and peptide building block for downstream derivatization in synthetic organic chemistry and applied peptide science.
1. Peptide Synthesis
Fmoc-alpha-allyl-DL-Gly-OH supports peptide building block preparation for automated peptide synthesis workflows where Fmoc removal and subsequent amide bond formation are required. The Fmoc-protected amine and free carboxylic acid arrangement enables peptide coupling using common peptide coupling strategies while maintaining the allyl functionality as a latent reactive motif. Incorporation of this alpha-allyl glycine unit can introduce conformational and reactivity features into peptide chains that later allow post-assembly functionalization. The racemic DL stereochemistry can be leveraged for generating libraries of diastereomeric peptide analogs when stereochemical purity is not the primary constraint. Downstream peptide analog construction and structure-activity relationship studies can then proceed through allyl-directed transformations to diversify side-chain chemistry.
2. Amino Acid Derivatization
Fmoc-alpha-allyl-DL-Gly-OH functions as an amino acid derivatization intermediate by combining an Fmoc-protected nitrogen with an allyl-bearing alpha substituent and a carboxylic acid for further conversion. The allyl group can be converted into alternative functional handles through oxidation to carbonyl derivatives, radical additions, or metathesis-based exchange, while the carboxyl group can be activated for esterification, amidation, or conversion into protected acid derivatives. The Fmoc group provides an orthogonal protection strategy that can be removed when switching between amino acid functionalization and peptide coupling steps. DL stereochemistry allows access to both enantiomeric configurations in one feedstock, which can simplify process development for screening workflows. Resulting products include functionalized amino acid esters, amides, and peptide-compatible analogs useful in synthetic methodology development and intermediate preparation.
3. Peptidomimetics Construction
Fmoc-alpha-allyl-DL-Gly-OH can be employed in peptidomimetics construction where amino acid-like backbones are combined with chemically transformable substituents to generate constrained or diversified scaffolds. The alpha-allyl motif serves as a synthetic handle for cyclization or cross-coupling routes after incorporation, enabling access to allyl-derived ring systems or substituted side-chain architectures. The protected amine and free acid support stepwise assembly into peptide-like frameworks, while subsequent allyl functional transformations can yield non-natural residues that modulate backbone rigidity and chemical recognition. Racemic availability may be applied in fragment-based molecular design and SAR studies to map how stereochemistry influences binding trends without requiring immediate enantiopure sourcing. This approach aligns with amino acid chemistry workflows that connect protected amino acid intermediates to downstream peptidomimetic diversification.
4. Bioconjugation Chemistry
Fmoc-alpha-allyl-DL-Gly-OH can serve as a precursor for bioconjugation chemistry by enabling the introduction of an allyl-functional amino acid unit into peptide carriers followed by post-conjugation modification. The allyl group can participate in orthogonal coupling and derivatization chemistries after Fmoc deprotection and peptide assembly, allowing attachment of labels, linkers, or reactive moieties to biomolecular scaffolds. The free carboxylic acid functionality supports conversion to activated intermediates for conjugation strategies that require carboxyl-reactive chemistry at a controlled stage. DL stereochemistry may be suitable for generating conjugate sets where stereochemical heterogeneity is acceptable for analytical mapping or method development. The resulting allyl-containing peptide or amino acid derivatives can be used to generate functional biomolecule conjugates for biochemical research and analytical investigations.
5. Process Chemistry Intermediate
Fmoc-alpha-allyl-DL-Gly-OH is suitable for process chemistry intermediate preparation where orthogonally protected amino acid functionality and a downstream-reactive alkene handle are both required. The Fmoc-protected amine supports robust handling during multi-step synthesis, while the free carboxylic acid enables conversion into activated forms for coupling or for producing ester and amide intermediates used in manufacturing routes. The allyl group can be retained through peptide-building steps and later transformed to meet specific intermediate specifications for fine chemical synthesis or specialty chemical production. DL stereochemistry can reduce upstream chiral resolution burden when racemate tolerance is acceptable for downstream screening or for producing stereochemically mixed libraries. This intermediate positioning supports scalable amino acid derivative synthesis and downstream functionalization strategies in industrial chemical manufacturing contexts.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.